Niagen Bioscience, Inc.
Company Information
Industry
Medicinal Chemicals & Botanical Products
SIC Code
2833
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
10900 WILSHIRE BLVD, LOS ANGELES, CA, 90024
Mailing Address
10900 WILSHIRE BLVD, LOS ANGELES, CA, 90024
Phone
310-388-6706
Fiscal Year End
1231
EIN
262940963
Financial Overview
FY2025
$17.38M
Net Income
$76.53M
Stockholders' Equity
$0.22
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 19, 2026 | View on SEC |
| 10-K Annual financial report | March 4, 2026 | View on SEC |
| 8-K Current report of material events | March 4, 2026 | View on SEC |
| 8-K Current report of material events | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 30, 2026 | View on SEC |
| 8-K Current report of material events | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | November 17, 2025 | View on SEC |
Annual Reports
10-K
March 4, 2026
- Niagen Bioscience achieved robust financial results in fiscal year 2025, returning to profitability with $15 million net income.
- The company reported substantial revenue growth of 45% to $125 million, driven by its lead product NeuroVita.
Material Events
8-K
Strategy Change
February 26, 2026
High Impact
- Niagen Bioscience sold its non-core 'analytical reference standards and services' division for $75 million cash.
- The company is making a strategic pivot to become a pure-play NAD+ science platform company.
Related Companies
Companies in the same industry (SIC: 2833)
MANNATECH INC
MTEX
Medicinal Chemicals & Botanical Products
Charlie's Holdings, Inc.
CHUC
Medicinal Chemicals & Botanical Products
Synergy CHC Corp.
SNYR
Medicinal Chemicals & Botanical Products
Tilray Brands, Inc.
TLRY
Medicinal Chemicals & Botanical Products
Raphael Pharmaceutical Inc.
RAPH
Medicinal Chemicals & Botanical Products
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.